Biosurgery Market Size, Growth and Analysis by Product (Bone-Graft Substitutes, Hemostatic Agents, Soft-Tissue Attachments, and Others), Source (Biological Products, Synthetic Products), Application (Neurological Surgery and Others)—Global Forecast till 2030
ID: MRFR/MED/4785-HCR | August 2022 | Region: Global | 100 Pages
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Biosurgery Market, by Product
6.1 Introduction
6.2 Bone-Graft Substitutes
6.2.1 Demineralized Bone Matrix
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.2.2 Synthetic Bone Grafts
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.2.3 Bone Morphogenetic Proteins
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.2.4 Other Bone-Graft Substitutes
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3 Hemostatic Agents
6.3.1 Thrombin-Based Hemostatic Agents
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3.3 Combination Hemostatic Agents
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.4 Soft-Tissue Attachments
6.4.1 Synthetic Meshes
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.4.2 Biological Meshes
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5 Surgical Sealants and Adhesives
6.5.1 Natural Sealants and Adhesives
6.5.1.1 Fibrin Sealants
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.1.2 Collagen-Based Sealants
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.1.3 Gelatin-Based Sealants
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.1.4 Albumin-Based Sealants
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.1.5 Other Natural Sealants
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.2 Synthetic Sealants and Adhesives
6.5.2.1 Peg Hydrogels
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.2.2 Cyanoacrylate-Based Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.2.3 Urethane-Based Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5.2.4 Other Synthetic Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6 Adhesion Barriers
6.6.1 Synthetic Adhesion Barriers
6.6.1.1 Hyaluronic Acid-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6.1.2 Regenerated Cellulose-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6.1.3 Peg-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6.1.4 Ther Synthetic Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6.2 Natural Adhesion Barriers
6.6.2.1 Collagen & Protein Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6.2.2 Fibrin-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.7 Staple-Line Reinforcement Agents
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 7. Global Biosurgery Market, by Source
7.1 Introduction
7.2 Biologics Products
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.3 Synthetic Products
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Biosurgery Market, by Application
8.1 Introduction
8.2 Neurological Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.3 General Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.4 Cardiovascular Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.5 Orthopedic Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.6 Thoracic Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.7 Gynecology Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.8 Reconstructive Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.9 Urology Surgery
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 9. Global Biosurgery Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 B.Braun Melsungen AG
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Baxter International, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Johnson & Johnson
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 C.R. Bard
11.4.1 Company Overview
11.4.2 Technology/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Medtronic, PLC.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Cohera Medical Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Integra Lifesciences Holdings Corporation
11.8.1 Overview
11.8.2 Product/ Technology Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Commonwealth Serum Laboratories (CSL)
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Hemostasis, LLC
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Sanofi
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Stryker Corporation
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Pfizer Inc.
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Cryolife, Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Kuros Biosciences Ltd.
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Biosurgery Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Biosurgery Market Synopsis, 2018–2023
Table 2 Global Biosurgery Market Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Biosurgery Market, by Region, 2018–2023 (USD Million)
Table 4 Global Biosurgery Market, by Product, 2018–2023 (USD Million)
Table 5 Global Biosurgery Market, by Source, 2018–2023 (USD Million)
Table 6 Global Biosurgery Market, by Application, 2018–2023 (USD Million)
Table 7 North America: Biosurgery Market, by Product, 2018–2023 (USD
Million)
Table 8 North America: Biosurgery Market, by Source, 2018–2023 (USD
Million)
Table 9 North America: Biosurgery Market, by Application, 2018–2023 (USD
Million)
Table 10 US: Biosurgery Market, by Product, 2018–2023 (USD Million)
Table 11 US: Biosurgery Market, by Source, 2018–2023 (USD Million)
Table 12 US: Biosurgery Market, by Application, 2018–2023 (USD Million)
Table 13 Canada: Biosurgery Market, by Product, 2018–2023 (USD Million)
Table 14 Canada: Biosurgery Market, by Source, 2018–2023 (USD Million)
Table 15 Canada: Biosurgery Market, by Application, 2018–2023 (USD
Million)
Table 16 South America: Biosurgery Market, by Product, 2018–2023 (USD
Million)
Table 17 South America: Biosurgery Market, by Source, 2018–2023 (USD
Million)
Table 18 South America: Biosurgery Market, by Application, 2018–2023 (USD
Million)
Table 19 Europe: Biosurgery Market, by Product, 2018–2023 (USD Million)
Table 20 Europe: Biosurgery Market, by Source, 2018–2023 (USD Million)
Table 21 Europe: Biosurgery Market, by Application, 2018–2023 (USD Million)
Table 22 Western Europe: Biosurgery Market, by Product, 2018–2023 (USD
Million)
Table 23 Western Europe: Biosurgery Market, by Source, 2018–2023 (USD
Million)
Table 24 Western Europe: Biosurgery Market, by Application, 2018–2023
(USD Million)
Table 25 Eastern Europe: Biosurgery Market, by Product, 2018–2023 (USD
Million)
Table 26 Eastern Europe: Biosurgery Market, by Source, 2018–2023 (USD
Million)
Table 27 Eastern Europe: Biosurgery Market, by Application, 2018–2023
(USD Million)
Table 28 Asia-Pacific: Biosurgery Market, by Product, 2018–2023 (USD
Million)
Table 29 Asia-Pacific: Biosurgery Market, by Source, 2018–2023 (USD
Million)
Table 30 Asia-Pacific: Biosurgery Market, by Application, 2018–2023 (USD
Million)
Table 31 Middle East & Africa: Biosurgery Market, by Product, 2018–2023
(USD Million)
Table 32 Middle East & Africa: Biosurgery Market, by Source, 2018–2023
(USD Million)
Table 33 Middle East & Africa: Biosurgery Market, by Application, 2018–2023
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Biosurgery Market
Figure 3 Segmentation Market Dynamics for Global Biosurgery Market
Figure 4 Global Biosurgery Market Share, by Product, 2020
Figure 5 Global Biosurgery Market Share, by Source, 2020
Figure 6 Global Biosurgery Market Share, by Application, 2020
Figure 7 Global Biosurgery Market Share, by Region, 2020
Figure 8 North America: Biosurgery Market Share, by Country, 2020
Figure 9 Europe: Biosurgery Market Share, by Country, 2020
Figure 10 Asia-Pacific: Biosurgery Market Share, by Country, 2020
Figure 11 Middle East & Africa: Biosurgery Market Share, by Country, 2020
Figure 12 Global Biosurgery Market: Company Share Analysis, 2020 (%)
Figure 13 B.Braun Melsungen AG: Key Financials
Figure 14 B.Braun Melsungen AG: Segmental Revenue
Figure 15 B.Braun Melsungen AG: Geographical Revenue
Figure 16 Baxter International, Inc.: Key Financials
Figure 17 Baxter International, Inc.: Segmental Revenue
Figure 18 Baxter International, Inc.: Geographical Revenue
Figure 19 Johnson & Johnson: Key Financials
Figure 20 Johnson & Johnson: Segmental Revenue
Figure 21 Johnson & Johnson: Geographical Revenue
Figure 22 C.R. Bard: Key Financials
Figure 23 C.R. Bard: Segmental Revenue
Figure 24 C.R. Bard: Geographical Revenue
Figure 25 Medtronic, PLC.: Key Financials
Figure 26 Medtronic, PLC.: Segmental Revenue
Figure 27 Medtronic, PLC.. Geographical Revenue
Figure 28 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Key Financials
Figure 29 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Segmental Revenue
Figure 30 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Geographical Revenue
Figure 31 Cohera Medical Inc.: Key Financials
Figure 32 Cohera Medical Inc.: Segmental Revenue
Figure 33 Cohera Medical Inc.: Geographical Revenue
Figure 34 Integra Lifesciences Holdings Corporation: Key Financials
Figure 35 Integra Lifesciences Holdings Corporation: Segmental Revenue
Figure 36 Integra Lifesciences Holdings Corporation: Geographical Revenue
Figure 37 Commonwealth Serum Laboratories (CSL) : Key Financials
Figure 38 Commonwealth Serum Laboratories (CSL) : Segmental Revenue
Figure 39 Commonwealth Serum Laboratories (CSL) : Geographical Revenue
Figure 40 Hemostasis, LLC: Key Financials
Figure 41 Hemostasis, LLC: Segmental Revenue
Figure 42 Hemostasis, LLC: Geographical Revenue
Figure 43 Sanofi: Key Financials
Figure 44 Sanofi: Segmental Revenue
Figure 45 Sanofi: Geographical Revenue
Figure 46 Stryker Corporation: Key Financials
Figure 47 Stryker Corporation: Segmental Revenue
Figure 48 Stryker Corporation: Geographical Revenue
Figure 49 Pfizer, Inc.: Key Financials
Figure 50 Pfizer, Inc.: Segmental Revenue
Figure 51 Pfizer, Inc.: Geographical Revenue
Figure 52 Cryolife, Inc.: Key Financials
Figure 53 Cryolife, Inc.: Segmental Revenue
Figure 54 Cryolife, Inc.: Geographical Revenue
Figure 55 Kuros Biosciences Ltd.: Key Financials
Figure 56 Kuros Biosciences Ltd.: Segmental Revenue
Figure 57 Kuros Biosciences Ltd.: Geographical Revenue
Biosurgery Market
The global biosurgery market is expected to grow at a CAGR 9.6% during the forecast period 2022-2030
$27,800.20 Million
Market Size
9.6%
CAGR
North America
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- Baxter International Inc.
- Braun Melsungen AG
- R. Bard
- Johnson & Johnson
- Medtronic PLC.
- MAQUET Holding B.V. & Co. Kg. (Getinge Group)
- Cohera Medical Inc.
- Integra Lifesciences Holdings Corporation
- Commonwealth Serum Laboratories (CSL)
- Hemostasis LLC
Drivers
- Growing geriatric population
- an increasing number of surgeries
- Rising occurrences of trauma and sports-related injuries
Biosurgery Market Overview
Biosurgery market is expected to grow during the forecast period (2022-2030) at a CAGR 8.40%. Biosurgery products minimize intra- and postoperative complications in a variety of treatments. These cutting-edge gadgets assist physicians in operating more effectively by decreasing surgery-related problems is costly and complex operations. The global biosurgery market is expected to develop significantly shortly as a result of increased investment, increased R&D spending, and aggressive methods used by top competitors such as new product launches. Various biosurgery products, such as hemostatic agents and surgical sealants, are increasingly being used in place of traditional sutures and staples during surgeries to control bleeding and cover the wound when using traditional goods is problematic or ineffective.
The market for biosurgery solutions is being driven by a growing focus on effective blood loss management and an increase in the number of elective surgeries. Globally, growth in elective surgical procedures can be ascribed to the prevalence of lifestyle problems and chronic diseases, as well as a growing geriatric population. Furthermore, the rising prevalence of severe traumatic injuries is fueling the demand for biosurgery products as a replacement for suture and ligature-based methods. Organic growth techniques such as new releases and developments are being used by vendors, resulting in a global increase in the availability of advanced items.
Segmentation
The global biosurgery market has been segmented on the basis of product, source, and application.
On the basis of product, the market has been classified as bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The bone-graft substitutes segment has been further divided into demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins, and other bone-graft substitutes. The hemostatic agents segment has been further divided into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, and combination hemostatic agents. The soft-tissue attachments segment has been classified as synthetic meshes and biological meshes. The surgical sealants and adhesives segment has been divided into natural and synthetic sealants and adhesives. The natural sealants sub-segment has been segmented into fibrin sealants, collagen-based sealants, gelatin-based sealants, albumin-based sealants, and other natural sealants. The synthetic sealants segment has been divided into peg hydrogels, cyanoacrylate-based sealants and adhesives, urethane-based sealants and adhesives, and others. Furthermore, the adhesion barriers segment has been sub-segmented into synthetic and natural adhesion barriers. The synthetic adhesion barriers segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers. The natural adhesion barriers segment includes collagen- and fibrin-based adhesion barriers.
The biosurgery market, by source, has been segmented into biological and natural products. On basis of application, the market has been divided into neurological surgery, general surgery, cardiovascular surgery, orthopedic surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and urology surgery.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biosurgery market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The biosurgery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Biosurgery Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global biosurgery market owing to the rising prevalence of chronic diseases in the aging population, increase in the number of surgical procedures, the presence of a well-established healthcare system, growing incidences of trauma-related injuries, and adoption of highly advanced technology. According to the American Association for the Surgery of Trauma, injury accounts for over 150,000 deaths and over 3 million non-fatal injuries are reported per year in the US.
The European market is expected to be the second-largest biosurgery market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of surgeries due to changing lifestyles is contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biosurgery market during the forecast period owing to the increasing prevalence of chronic diseases, rising investments in healthcare and expansions by market players in the region. For instance, in February 2014, Cryolife, Inc. established a new subsidiary in Asia-Pacific.
The market in the Middle East & Africa is expected to account for the smallest share of the global biosurgery market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Company Profiles
- Baxter International, Inc.
- Braun Melsungen AG
- R. Bard
- Johnson & Johnson
- Medtronic, PLC.
- MAQUET Holding B.V. & Co. Kg. (Getinge Group)
- Cohera Medical Inc.
- Integra Lifesciences Holdings Corporation
- Commonwealth Serum Laboratories (CSL)
- Hemostasis, LLC
- Sanofi
- Pfizer Inc.
- Stryker Corporation
- Cryolife, Inc.
- Kuros Biosciences Ltd.
Research Methodology
Market Research Future analysis is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, competitive landscape (CL), market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the biosurgery market will be headed in the next five to 10 years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories are studied in each region and are estimated based on primary and secondary research.
- Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed over the next five to 10 years.
- Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global biosurgery market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, regional markets, and developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organizations of chemical manufacturers, and paid databases, among others.
Recent Development
Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip received 510 (k) clearance from the US FDA in February 2020. This product is a staple line reinforcing agent that is used to control bleeding during bariatric and other surgical procedures. Integra LifeSciences Holdings Corp. also introduced AmnioExcel Plus Placental Allograft Membrane for soft tissue healing.
Orthofix Medical Inc. (US) released the O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, ready-to-use cervical and lumbar spacers for allograft surgeries, in October 2020. This corporation is one of the top companies in terms of market share and currently controls the market.
Biosurgery Market, by Product
- Bone-Graft Substitutes
- Demineralized Bone Matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Other Bone-Graft Substitutes
- Hemostatic Agents
- Thrombin-Based Hemostatic Agents
- Oxidized Regenerated Cellulose-Based Hemostatic Agents
- Combination Hemostatic Agents
- Soft-Tissue Attachments
- Synthetic Meshes
- Biological Meshes
- Surgical Sealants and Adhesives
- Natural Sealants and Adhesives
- Fibrin Sealants
- Collagen-Based Sealants
- Gelatin-Based Sealants
- Albumin-Based Sealants
- Other Natural Sealants
- Synthetic Sealants and Adhesives
- Peg Hydrogels
- Cyanoacrylate-Based Sealants and Adhesives
- Urethane-Based Sealants and Adhesives
- Other Synthetic Sealants
- Adhesion Barriers
- Synthetic Adhesion Barriers
- Hyaluronic Acid-Based Adhesion Barriers
- Regenerated Cellulose-Based Adhesion Barriers
- Peg-Based Adhesion Barriers
- Ther Synthetic Adhesion Barriers
- Natural Adhesion Barriers
- Collagen and Protein Adhesion Barriers
- Fibrin-Based Adhesion Barriers
- Staple-Line Reinforcement Agents
Biosurgery Market, by Source
- Biological Products
- Synthetic Products
Biosurgery Market, by Application
- Neurological Surgery
- General Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Thoracic Surgery
- Reconstructive Surgery
- Urology Surgery
Biosurgery Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Intended Audience
- Biosurgery product manufacturers
- Biosurgery product distributors and suppliers
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Market research and consulting
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2030: Significant Value |
| CAGR | 8.40% (2020-2030) |
| Base Year | 2019 |
| Forecast Period | 2020-2030 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product, Source, Application, |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Baxter International, Inc., B. Braun Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC, Sanofi, Pfizer Inc., Stryker Corporation |
| Key Market Opportunities | Increasing research, development and growing number of surgeries due to changing lifestyles is contributing to the growth of the market |
| Key Market Drivers |
|
